Population Pharmacokinetics of Vamorolone (VBP15) in Healthy Men and Boys With Duchenne Muscular Dystrophy-Reference-Cited by-同舟云学术

Population Pharmacokinetics of Vamorolone (VBP15) in Healthy Men and Boys With Duchenne Muscular Dystrophy

Published:2019-02-11 Issue:7 Volume:59 Page:979-988
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Mavroudis Panteleimon D.¹,van den Anker John²³,Conklin Laurie S.²³,Damsker Jesse M.²,Hoffman Eric P.²⁴,Nagaraju Kanneboyina²⁴,Clemens Paula R.⁵^ORCID,Jusko William J.¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences; University at Buffalo; State University of New York; Buffalo NY USA

2. ReveraGen Biopharma; Rockville MD USA

3. Children's National Health System; Washington DC USA

4. Binghamton University-SUNY; Binghamton NY USA

5. University of Pittsburgh and Department of Veterans Affairs Medical Center; Pittsburgh PA USA

Funder

National Institute of General Medical Sciences

Eunice Kennedy Shriver National Institute of Child Health and Human Development

National Institute for Arthritis and Musculoskeletal and Skin Diseases

DuchenneUK [UK]

National Institutes of Health NCATS TRND program (Therapeutics for Rare and Neglected Disease)

MuscularDystrophy Association (USA)

Duchenne Children's Trust [UK]

Joining Jack [UK]

Foundation to Eradicate Duchenne (USA)

National Institute for Neurological Diseases and Stroke

Parent Project Muscular Dystrophy (USA)

CureDuchenne (USA)

Save Our Sons (Aus)

Pietro's Fight (USA)

Alex's Wish (UK)

Michael's Cause (USA)

Ryan's Quest (USA)

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.1388/fullpdf

Reference46 articles.

1. Dystrophin: the protein product of the Duchenne muscular dystrophy locus;Hoffman;Cell,1987

2. Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches;Fairclough;Nat Rev Genet,2013

3. Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy;Chen;Neurology,2005

4. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle;Haslett;Proc Natl Acad Sci U S A,2002

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing Pharmacogenomic loci Associated with the Pharmacokinetics of Vamorolone in Boys with Duchenne Muscular Dystrophy;The Journal of Clinical Pharmacology;2024-04-29

2. Vamorolone: revolutionizing Duchenne muscular dystrophy treatment;International Journal of Scientific Reports;2024-04-24

3. Vamorolone: First Approval;Drugs;2023-12-16

4. Considering the Promise of Vamorolone for Treating Duchenne Muscular Dystrophy;Journal of Neuromuscular Diseases;2023-11-07

5. Emerging therapies for Duchenne muscular dystrophy;The Lancet Neurology;2022-09